Gene · 658
Papers1,863
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 1,863
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Etiopathogenetic Mechanisms in Diverticular Disease of the Colon. | Cell Mol Gastroenterol Hepatol | 2020 | 31351939 | PubTator, text mining | PubMed |
| Down-regulated hsa_circ_0067934 facilitated the progression of gastric cancer by sponging hsa-mir-4705 to downgrade the expression of BMPR1B. | Transl Cancer Res | 2019 | 35117027 | PubTator, text mining | PubMed |
| Split Hand Foot Malformation Syndrome: A Novel Heterozygous FGFR1 Mutation Detected by Next Generation Sequencing. | Curr Genomics | 2019 | 31929729 | PubTator, text mining | PubMed |
| Inflammatory Profile and Osteogenic Potential of Fracture Haematoma in Humans. | J Clin Med | 2019 | 31878248 | PubTator, text mining | PubMed |
| IBI: Identification of Biomarker Genes in Individual Tumor Samples. | Front Genet | 2019 | 31850079 | PubTator, text mining | PubMed |
| Copresentation of BMP-6 and RGD Ligands Enhances Cell Adhesion and BMP-Mediated Signaling. | Cells | 2019 | 31847477 | PubTator, text mining | PubMed |
| The Butterfly Effect of RNA Alterations on Transcriptomic Equilibrium. | Cells | 2019 | 31847302 | PubTator, text mining | PubMed |
| TGF-β and microRNA Interplay in Genitourinary Cancers. | Cells | 2019 | 31842336 | PubTator, text mining | PubMed |
| Increased BMPR1A Expression Enhances the Adipogenic Differentiation of Mesenchymal Stem Cells in Patients with Ankylosing Spondylitis. | Stem Cells Int | 2019 | 31827527 | PubTator, text mining | PubMed |
| BMPR2 acts as a gatekeeper to protect endothelial cells from increased TGFβ responses and altered cell mechanics. | PLoS Biol | 2019 | 31826007 | PubTator, text mining | PubMed |
| Specification of BMP Signaling. | Cells | 2019 | 31817503 | PubTator, text mining | PubMed |
| The shift in the balance between osteoblastogenesis and adipogenesis of mesenchymal stem cells mediated by glucocorticoid receptor. | Stem Cell Res Ther | 2019 | 31805987 | PubTator, text mining | PubMed |
| Analysis of miRNA expression profiles in the liver of Clock Δ19 mutant mice. | PeerJ | 2019 | 31799078 | PubTator, text mining | PubMed |
| Mutually reinforcing effects of genetic variants and interferon-β 1a therapy for pulmonary arterial hypertension development in multiple sclerosis patients. | Pulm Circ | 2019 | 31798832 | PubTator, text mining | PubMed |
| [Targeted Therapies for Driver Gene Mutation-positive Lung Cancer Patients with Brain Metastasis]. | Zhongguo Fei Ai Za Zhi | 2019 | 31771742 | PubTator, text mining | PubMed |
| Recovery in the Myogenic Program of Congenital Myotonic Dystrophy Myoblasts after Excision of the Expanded (CTG)n Repeat. | Int J Mol Sci | 2019 | 31766224 | PubTator, text mining | PubMed |
| lncRNAs: function and mechanism in cartilage development, degeneration, and regeneration. | Stem Cell Res Ther | 2019 | 31753016 | PubTator, text mining | PubMed |
| Targeting bone morphogenetic protein receptor 2 sensitizes lung cancer cells to TRAIL by increasing cytosolic Smac/DIABLO and the downregulation of X-linked inhibitor of apoptosis protein. | Cell Commun Signal | 2019 | 31744505 | PubTator, text mining | PubMed |
| Novel risk genes and mechanisms implicated by exome sequencing of 2572 individuals with pulmonary arterial hypertension. | Genome Med | 2019 | 31727138 | PubTator, text mining | PubMed |
| Druggable Biochemical Pathways and Potential Therapeutic Alternatives to Target Leukemic Stem Cells and Eliminate the Residual Disease in Chronic Myeloid Leukemia. | Int J Mol Sci | 2019 | 31717629 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/658/papers?page=39